Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Opposing sides continue ICD-10 debate

In the ongoing saga of ICD-10 implementation, opposing sides continue to advocate their positions.

U.S. healthcare spending at historic lows

U.S. healthcare spending grew at the slowest rate on record since 1960, according to a report from the Office of the Actuary at the Centers for Medicare & Medicaid Services.

Hearings scheduled to consider single-payer healthcare in N.Y.

Six public hearings are scheduled to explore state legislation that would establish single-payer health insurance throughout New York, reports Ithaca Journal. 

U.S. healthcare spending growth slowest since 1960

U.S. healthcare spending rose 3.6 percent in 2013, which is the slowest rate on record since 1960, reports The Hill. 

HealthCare.gov’s small business insurance marketplace goes live

A year after postponing the launch of the small business part of HealthCare.gov, it has gone live with reports of only modest technical flaws, reports Washington Post.

Thumbnail

CMS to issue draft ACO regulations

The Centers for Medicare & Medicaid Services is expected to publish draft regulations to revise and expand the use of accountable care contracts under the Medicare Shared Savings Program, reports Modern Healthcare. 

Burwell calls for transparency following enrollment data error

Health & Human Services Secretary Sylvia Mathews Burwell is calling for “a culture of increased transparency” after Affordable Care Act enrollment data accidentally were inflated with dental plan customers, according to Bloomberg Businessweek.

Obama sued by House Republicans over ACA

Republications in the House of Representatives have filed a lawsuit against President Obama over the Affordable Care Act, reports Los Angeles Times.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.